Chiron Shareholders Approve Novartis Acquisition
20 April 2006 - 2:11AM
Business Wire
Chiron Corporation (NASDAQ:CHIR) today announced that Chiron
shareholders have approved the amended merger agreement under which
Novartis AG (NYSE:NVS) will acquire all Chiron shares it doesn't
already own for $48.00 per share in cash. At a special meeting of
Chiron shareholders held today, the merger was approved with more
than 85 percent of Chiron's total outstanding shares cast in favor
of the merger. As all necessary regulatory approvals were
previously received, Chiron expects the merger to close on
Thursday, April 20, 2006, at 12:01 a.m. PDT. About Chiron Chiron
delivers innovative and valuable products to protect human health
by advancing pioneering science across the landscape of
biotechnology. The company works to deliver on the limitless
promise of science and make a positive difference in people's
lives. For more information about Chiron, please visit
www.chiron.com.
Chiron (NASDAQ:CHIR)
Historical Stock Chart
From May 2024 to Jun 2024
Chiron (NASDAQ:CHIR)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Chiron (MM) (NASDAQ): 0 recent articles
More Chiron Corporation News Articles